IRIS Accounts Production v26.1.10.60 11799744 Board of Directors 1.4.23 28.9.24 28.9.24 0 0 false true false false true false A Ordinary 1.51848 C Ordinary 0.61600 B1 Ordinary 1.00007 B2 Ordinary 0.46700 B3 Ordinary 0.35300 A Ordinary 1.51848 C Ordinary 0.61600 B1 Ordinary 1.00007 B2 Ordinary 0.46700 B3 Ordinary 0.35300 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 11799744 2023-03-31 11799744 2024-09-28 11799744 2023-04-01 2024-09-28 11799744 2022-03-31 11799744 2022-04-01 2023-03-31 11799744 2023-03-31 11799744 ns15:EnglandWales 2023-04-01 2024-09-28 11799744 ns14:PoundSterling 2023-04-01 2024-09-28 11799744 ns10:Director1 2023-04-01 2024-09-28 11799744 ns10:PrivateLimitedCompanyLtd 2023-04-01 2024-09-28 11799744 ns10:SmallEntities 2023-04-01 2024-09-28 11799744 ns10:AuditExempt-NoAccountantsReport 2023-04-01 2024-09-28 11799744 ns10:SmallCompaniesRegimeForDirectorsReport 2023-04-01 2024-09-28 11799744 ns10:SmallCompaniesRegimeForAccounts 2023-04-01 2024-09-28 11799744 ns10:FullAccounts 2023-04-01 2024-09-28 11799744 ns10:OrdinaryShareClass1 2023-04-01 2024-09-28 11799744 ns10:OrdinaryShareClass2 2023-04-01 2024-09-28 11799744 ns10:OrdinaryShareClass3 2023-04-01 2024-09-28 11799744 ns10:OrdinaryShareClass4 2023-04-01 2024-09-28 11799744 ns10:OrdinaryShareClass5 2023-04-01 2024-09-28 11799744 ns10:Director2 2023-04-01 2024-09-28 11799744 ns10:RegisteredOffice 2023-04-01 2024-09-28 11799744 ns5:CurrentFinancialInstruments 2024-09-28 11799744 ns5:CurrentFinancialInstruments 2023-03-31 11799744 ns5:Non-currentFinancialInstruments 2024-09-28 11799744 ns5:Non-currentFinancialInstruments 2023-03-31 11799744 ns5:ShareCapital 2024-09-28 11799744 ns5:ShareCapital 2023-03-31 11799744 ns5:SharePremium 2024-09-28 11799744 ns5:SharePremium 2023-03-31 11799744 ns5:RetainedEarningsAccumulatedLosses 2024-09-28 11799744 ns5:RetainedEarningsAccumulatedLosses 2023-03-31 11799744 ns5:CostValuation 2023-03-31 11799744 ns5:AdditionsToInvestments 2024-09-28 11799744 ns5:CostValuation 2024-09-28 11799744 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-09-28 11799744 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2023-03-31 11799744 ns10:OrdinaryShareClass1 2024-09-28 11799744 ns10:OrdinaryShareClass2 2024-09-28 11799744 ns10:OrdinaryShareClass3 2024-09-28 11799744 ns10:OrdinaryShareClass4 2024-09-28 11799744 ns10:OrdinaryShareClass5 2024-09-28 11799744 1 2023-04-01 2024-09-28

REGISTERED NUMBER: 11799744 (England and Wales)

Unaudited Financial Statements

for the Period

1 April 2023 to 28 September 2024

for

TRIO HEALTHCARE HOLDINGS LTD

TRIO HEALTHCARE HOLDINGS LTD (REGISTERED NUMBER: 11799744) |

Contents of the Financial Statements

for the Period 1 April 2023 to 28 September 2024

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| TRIO HEALTHCARE HOLDINGS LTD |

Company Information

for the Period 1 April 2023 to 28 September 2024

| Directors: | R J Anderson

| S J Anderson

| Registered office: | Pall Mall

| 1 Pollen Square

| 59 King Street

| Manchester

| M2 4PD

| Registered number: | 11799744 (England and Wales)

| Accountants: | S&W Partners (Manchester) Limited

| Accountants

| Pall Mall

| 1 Pollen Square

| 59 King Street

| Manchester

| M2 4PD

TRIO HEALTHCARE HOLDINGS LTD (REGISTERED NUMBER: 11799744) |

Balance Sheet

28 September 2024

| 2024 | 2023 |

| Notes | £ | £ | £ | £ |

Fixed assets

Investments | 5 | - |  | 11,456,742 |  |

Current assets

Debtors | 6 | 2 |  | 105,300 |  |

Cash at bank | 20 |  | 494 |  |

22 |  | 105,794 |  |

Creditors

Amounts falling due within one year | 7 | 4,803,849 |  | 516,762 |  |

Net current liabilities | (4,803,827 | ) | (410,968 | ) |

Total assets less current liabilities | (4,803,827 | ) | 11,045,774 |  |

Creditors

Amounts falling due after more than one year | 8 | - |  | 3,401,794 |  |

Net (liabilities)/assets | (4,803,827 | ) | 7,643,980 |  |

Capital and reserves

Called up share capital | 9 | 4 |  | 4 |  |

Share premium | 8,412,187 |  | 8,412,187 |  |

Retained earnings | (13,216,018 | ) | (768,211 | ) |

Shareholders' funds | (4,803,827 | ) | 7,643,980 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 28 September 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 28 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 August 2026 and were signed on its behalf by:

R J Anderson - Director

TRIO HEALTHCARE HOLDINGS LTD (REGISTERED NUMBER: 11799744) |

Notes to the Financial Statements

for the Period 1 April 2023 to 28 September 2024

1. | Statutory information

| Trio Healthcare Holdings Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | Statement of compliance

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. | Accounting policies

| Basis of preparing the financial statements

| The financial statements have been prepared under the historical cost convention.

| The director intends to wind up the company within twelve months from the date of signing these financial statements. Consequently, the Company is not regarded as a going concern and these financial statements have not been prepared on a going concern basis. These financial statements have been prepared on a basis that is consistent with Section 1A of FRS 102 but amended to reflect the fact that the going concern basis is not appropriate.

| Investments in subsidiaries

| Investments in subsidiary undertakings are recognised at cost less any provision for impairment.

| Taxation

| Taxation for the period comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

4. | Employees and directors

| The average number of employees during the period was NIL (2023 - NIL).

TRIO HEALTHCARE HOLDINGS LTD (REGISTERED NUMBER: 11799744) |

Notes to the Financial Statements - continued

for the Period 1 April 2023 to 28 September 2024

5. | Fixed asset investments

| Shares in

| group

| undertaking

£ |

| Cost

| At 1 April 2023 | 11,456,742 |  |

| Additions | 241,975 |  |

| At 28 September 2024 | 11,698,717 |  |

| Provisions

| Provision for period | 11,698,717 |  |

| At 28 September 2024 | 11,698,717 |  |

| Net book value

| At 28 September 2024 | - |  |

| At 31 March 2023 | 11,456,742 |  |

6. | Debtors: amounts falling due within one year |

2024 | 2023 |

£ | £ |

| Other debtors | 2 |  | 105,300 |  |

7. | Creditors: amounts falling due within one year |

2024 | 2023 |

£ | £ |

| Trade creditors | 153,453 |  | 21,341 |  |

| Other creditors | 4,650,396 |  | 495,421 |  |

4,803,849 |  | 516,762 |  |

8. | Creditors: amounts falling due after more than one year |

2024 | 2023 |

£ | £ |

| Other creditors | - |  | 3,401,794 |  |

TRIO HEALTHCARE HOLDINGS LTD (REGISTERED NUMBER: 11799744) |

Notes to the Financial Statements - continued

for the Period 1 April 2023 to 28 September 2024

9. | Called up share capital

**ERROR - CONFLICTS FOUND BETWEEN POSTINGS AND SHARE REGISTER - PLEASE REVIEW EXCEPTION REPORT (EXR).

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2024 | 2023 |

| value: | £ | £ |

| 1,518 | A Ordinary | £1.51 | 848 | 2 |  | 2 |  |

| 616 | C Ordinary | 61.6p | 1 |  | 1 |  |

| 1,000 | B1 Ordinary | £1.00 | 007 | 1 |  | 1 |  |

| 467 | B2 Ordinary | 46.7p | - |  | - |  |

| 353 | B3 Ordinary | 35.3p | - |  | - |  |

| 88 | M Ordinary | 8.8p | - |  | - |  |

4 |  | 4 |  |

10. | Going concern

| The Directors and Shareholders have decided to wind up the Company subsequently to the year-end. Accordingly, these financial statements have not been prepared on a going concern basis but instead, have been prepared on a basis that is consistent with Section 1A of Financial Reporting Standard 102 but amended to reflect the fact that the going concern basis is not appropriate.. Where applicable, this generally involves:

| - Writing down assets fair value less costs of disposal

| - Providing for contractual commitments which may have been onerous as a consequence of the decision to wind up the company.

| - Reclassifying assets or liabilities from non-current to current

| The financial statements do not include a provision for any costs of wind up, other than those committed to at the statement of financial postilion date.

11. | Post balance sheet events

| After the reporting period the Director has decided to wind up the Company. The going concern basis is not appropriate and the director has therefore prepared the financial statements on a basis that is consistent with Section 1A of Financial Reporting Standard 102 but amended to reflect the fact that the going concern basis is not appropriate.

| There have been no other significant events subsequent to the financial year end that would required adjustment or disclosure in the financial statements.